Mind & Matter
Mind & Matter
Scarring, Fibrosis, Oxidative Stress, and Psilocybin & Aging | Louise Hecker | 252
0:00
-56:44

Paid episode

The full episode is only available to paid subscribers of Mind & Matter

Scarring, Fibrosis, Oxidative Stress, and Psilocybin & Aging | Louise Hecker | 252

Aging, tissue repair, and the longevity benefits of psilocin.

Wide release date: September 16, 2025

Episode Summary: Dr. Louise Hecker discusses her research on tissue repair and regeneration, explaining how fibroblasts drive wound healing by forming scar tissue but fail to resolve properly with age, leading to fibrotic diseases like pulmonary fibrosis and liver cirrhosis; they discuss aging hallmarks such as oxidative stress and telomere shortening, and highlight Hecker's study showing psilocybin's active metabolite, psilocin, extends cellular lifespan in lab cultures by reducing oxidants and preserving telomeres, while monthly doses in aged mice improved appearance and survival rates.

About the guest: Louise Hecker, PhD is an Associate Professor of Medicine at Baylor College of Medicine, specializing in repair and regeneration processes, particularly in aging and fibrotic diseases.

Discussion Points:

  • Fibroblasts are dormant cells that activate during injury to pull wounds closed and form scars, then de-differentiate or die; aging impairs this, causing persistent scarring and disease.

  • Aging reduces the body's regenerative capacity; different organs vary in repair efficiency, with skin healing better than heart tissue.

  • Oxidative stress, like "rust" in the body, accumulates with age due to imbalanced reactive oxygen species production and antioxidant defenses, contributing to cellular damage.

  • Telomeres act as protective DNA caps that shorten with cell divisions, serving as a hallmark of biological aging; sirtuins are master regulators influencing aging processes.

  • Hecker's in vitro study showed psilocin dose-dependently extended fibroblast lifespan by 29-50%, lowering oxidative stress below young cell levels and preserving telomeres.

  • In aged mice (equivalent to 60-65 human years), monthly high-dose psilocybin (15 mg/kg) led to healthier appearance, regrown fur, and 80% survival when controls reached 50% mortality after 10 months.

  • Psilocybin's effects may stem from serotonin receptors expressed in many cell types beyond the brain, suggesting broader anti-aging potential; future work explores mechanisms, optimal dosing, and applications for age-related diseases.

  • Fungi like magic mushrooms represent an under-explored "kingdom" for medicine, with psilocybin's durable effects hinting at systemic impacts on aging.

Reference Paper:

  • Study: Psilocybin treatment extends cellular lifespan and improves survival of aged mice

Related content:

  • M&M 69: Cellular Aging, Oxidative Stress, Antioxidants, Life Extension & Health Supplements | Leonard Guarente

*Not medical advice.




Share


Episode Chapters:

00:00:00 Intro

05:34 Fibroblasts & Wound Healing

10:42 Psilocybin Research Origins

16:05 Oxidative Stress & Aging

22:17 In Vitro Psilocin Study

29:15 Hallmarks of Aging Effects

35:37 Mouse Study Design

40:43 Dosing & Metabolism

46:23 Future Directions

53:03 Fibrosis & Organ Repair


Full AI-generated transcript below. Beware of typos & mistranslations!

Listen to this episode with a 7-day free trial

Subscribe to Mind & Matter to listen to this post and get 7 days of free access to the full post archives.